David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVC
2676
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $579K | ﹤0.01% |
+17,557
| New | +$566K |
|
|
CSR
2677
Centerspace
CSR
$907M
| $577K | ﹤0.01% |
7,949
+5,983
| +304% | +$393K |
|
2678
EnerSys
ENS
$6.93B
| $577K | ﹤0.01% |
+10,347
| New | +$534K |
|
2679
Royal Gold
RGLD
$22.6B
| $575K | ﹤0.01% |
11,204
-18,627
| -62% | -$759K |
|
|
LUMO
2680
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $575K | ﹤0.01% |
3,511
-2
| -0.1% | -$405 |
|
|
DYN
2681
PUT
DELISTED
Dynegy, Inc.
DYN
| $575K | ﹤0.01% |
40,000
-4,400
| -10% | -$50.1K |
|
|
APOL
2682
PUT
DELISTED
Apollo Education Group Inc Class A
APOL
| $575K | ﹤0.01% |
70,000
-169,600
| -71% | -$1.35M |
|
|
KEM
2683
DELISTED
KEMET Corporation
KEM
| $572K | ﹤0.01% |
296,374
-90,592
| -23% | -$159K |
|
2684
Mueller Water Products
MWA
$3.89B
| $571K | ﹤0.01% |
57,769
-96,270
| -62% | -$823K |
|
|
MKTO
2685
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $571K | ﹤0.01% |
29,169
+11,526
| +65% | +$219K |
|
2686
Vaalco Energy
EGY
$605M
| $569K | ﹤0.01% |
605,573
+73,268
| +14% | +$89.1K |
|
2687
PUT
Minerals Technologies
MTX
$2.24B
| $569K | ﹤0.01% |
+10,000
| New | +$467K |
|
|
CDI
2688
DELISTED
CDI Corp.
CDI
| $568K | ﹤0.01% |
90,416
-16,163
| -15% | -$84.5K |
|
2689
CALL
Bunge Global
BG
$21.5B
| $567K | ﹤0.01% |
10,000
-28,100
| -74% | -$1.6M |
|
|
2690
PUT
Bunge Global
BG
$21.5B
| $567K | ﹤0.01% |
10,000
-500
| -5% | -$28.5K |
|
|
KNDI
2691
Kandi Technologies Group
KNDI
$65.3M
| $565K | ﹤0.01% |
78,495
+61,957
| +375% | +$481K |
|
|
JUNO
2692
DELISTED
Juno Therapeutics, Inc.
JUNO
| $563K | ﹤0.01% |
14,769
-4,317
| -23% | -$150K |
|
2693
Dave & Buster's
PLAY
$350M
| $562K | ﹤0.01% |
14,502
-95,187
| -87% | -$3.48M |
|
2694
PUT
Acadia Pharmaceuticals
ACAD
$5.27B
| $559K | ﹤0.01% |
+20,000
| New | +$436K |
|
2695
Acacia Research
ACTG
$440M
| $559K | ﹤0.01% |
147,541
+49,424
| +50% | +$181K |
|
|
MRIN
2696
DELISTED
Marin Software
MRIN
| $559K | ﹤0.01% |
4,410
+1,075
| +32% | +$141K |
|
|
PPL
2697
PPL Corp
PPL
$26.5B
| $559K | ﹤0.01% |
+14,690
| New | +$522K |
|
2698
Commercial Vehicle Group
CVGI
$124M
| $558K | ﹤0.01% |
210,529
+79,323
| +60% | +$206K |
|
2699
Ligand Pharmaceuticals
LGND
$5.58B
| $558K | ﹤0.01% |
8,348
-57,460
| -87% | -$3.49M |
|
|
TFCFA
2700
PUT
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $558K | ﹤0.01% |
20,000
-62,800
| -76% | -$1.68M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.